Therapeutic Potential of Glutaminase Inhibition Targeting Metabolic Adaptations in Resistant Melanomas to Targeted Therapy
Laura Soumoy(University of Mons), Fabrice Journé(Université Libre de Bruxelles)
Cited by 5
Related Papers
Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells
|British Journal of Cancer|2004|22
Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells
|Breast Cancer Research|2008|15
ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy
|Cancer Cell International|2024|9